People: Alexion Pharmaceuticals, Inc. (ALXN.O)

ALXN.O on Nasdaq

46.91USD
9 Feb 2010
Price Change (% chg)

$0.94 (+2.04%)
Prev Close
$46.91
Open
--
Day's High
$47.02
Day's Low
$46.10
Volume
446,628
Avg. Vol
683,671
52-wk High
$49.57
52-wk Low
$30.78

view people for:

Link, Max 

Brief Biography

Max Link, Ph.D. has been the Chairman of the Board of Directors of Alexion Pharmaceuticals since December 2002 and a director of Alexion since April 1992. From March 2001 to September 2003, Dr. Link was Chairman of the Board and CEO of Centerpulse AG, a medical implant company. From May 1993 to June 1994, Dr. Link was Chief Executive Officer of Corange (Bermuda), the parent company of Boehringer Mannheim Therapeutics, Boehringer Mannheim Diagnostics and DePuy Orthopedics. From 1992 to 1993, Dr. Link was Chairman of the Board of Sandoz Pharma, Ltd., a manufacturer of pharmaceutical products. From 1987 to 1992, Dr. Link was the Chief Executive Officer of Sandoz Pharma and a member of the Executive Board of Sandoz, Ltd., Basel. Prior to 1987, Dr. Link served in various capacities with the United States operations of Sandoz, including as President and Chief Executive Officer. Dr. Link is the chairman of the board of directors of CytRx Corporation, and Celsion Corporation, and is also a director of Discovery Labs, Inc., each a publicly held pharmaceutical and/or life-science company. Dr. Link holds a Ph.D. in economics from University of St. Gallen (Switzerland).

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total
Link, Max --
Bell, Leonard 3,939,350
Sinha, Vikas 2,072,930
Squinto, Stephen 1,516,620
Rother, Russell --
Dubin, Thomas 1,427,290
As Of 30 Dec 2008
view people for: